ExxPharma Therapeutics and Halo Pharmaceutical have entered into a collaboration agreement to develop and manufacture Phase I - III pharmaceutical products using ExxPharma’s proprietary technologies and Halo’s GMP manufacturing facility. All product development activities are carried out at ExxPharma’s research and development laboratories. Upon completion of the development phase, the technologies are transferred to the Halo Pharmaceutical for clinical test materials manufacturing and commercial production.


ExxPharma Therapeutics has  also signed an option agreement with Fortress Biotech to develop products for Fortress using ExxPharma’s proprietary drug delivery systems and manufacturing technologies.